BU study reveals crucial signaling pathway that drives head and neck cancers

FHS
June 23, 2023
11:45 pm

Despite advances in defining the genomic characteristics of head and neck cancers, these malignancies continue to rank among the deadliest cancers with few targeted therapies available.

Ocaliva will continue to be available in the EU following European court’s decision

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 6, 2024

Skipping Hand Hygiene Before Donning Gloves May Be Just as Safe, Trial Suggests

Among healthcare providers, a direct-gloving strategy led to improved adherence and was found to be as safe as the current practice of hand hygiene prior

October 28, 2023

Phebra, University of Wollongong to develop cancer therapies

Andre Vlok and Mal Eutick from Phebra with Carolyn Dillon and Judith Carrall from UOW School of Chemistry and Molecular Bioscience. Credit: University of Wollongong.

August 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.